GADEWAR, M. and LAL, B. 2022. MOLECULAR DOCKING AND SCREENING OF DRUGS FOR 6LU7 PROTEASE INHIBITOR AS A POTENTIAL TARGET FOR COVID-19. International Journal of Applied Pharmaceutics. 14, 1 (Jan. 2022), 100–105. DOI:https://doi.org/10.22159/ijap.2022v14i1.43132.